» Articles » PMID: 38005844

Patterns of Circulating Cytokines and Vascular Markers' Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients

Abstract

COVID-19's severity has been associated with a possible imbalance in the cross-regulation of cytokines and vascular mediators. Since the beginning of the pandemic, kidney transplant recipients (KTRs) have been identified as patients of high vulnerability to more severe diseases. Thus, aiming to describe the patterns of cytokines and vascular mediators and to trace patients' differences according to their KTR status, this prospective study enrolled 67 COVID-19 patients (20 KTRs) and 29 non-COVID-19 controls before vaccination. A panel comprising 17 circulating cytokines and vascular mediators was run on samples collected at different time points. The cytokine and mediator patterns were investigated via principal component analysis (PCA) and correlation-based network (CBN). In both groups, compared to their respective controls, COVID-19 was associated with higher levels of cytokines and vascular mediators. Differentiating between the KTRs and non-KTRs, the number of correlations was much higher in the non-KTRs (44 vs. 14), and the node analysis showed the highest interactions of NGAL and sVCAM-1 in the non-KTRs and KTRs (9 vs. 4), respectively. In the PCA, while the non-KTRs with COVID-19 were differentiated from their controls in their IL-10, IFN-α, and TNF-α, this pattern was marked in the NGAL, sVCAM-1, and IL-8 of the KTRs.

Citing Articles

Proteomic profiling of peripheral blood mononuclear cells reveals immune dysregulation and metabolic alterations in kidney transplant recipients with COVID-19.

Leite G, Sousa M, Rodrigues L, Brunialti M, Medina-Pestana J, Butler J Front Immunol. 2024; 15:1508110.

PMID: 39737170 PMC: 11683116. DOI: 10.3389/fimmu.2024.1508110.

References
1.
Requiao-Moura L, Sandes-Freitas T, Viana L, Cristelli M, Modelli de Andrade L, Garcia V . High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study. PLoS One. 2021; 16(7):e0254822. PMC: 8318290. DOI: 10.1371/journal.pone.0254822. View

2.
Marshall J . Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov. 2003; 2(5):391-405. DOI: 10.1038/nrd1084. View

3.
Young B, Ong S, Ng L, Anderson D, Chia W, Chia P . Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2020; 73(9):e2932-e2942. PMC: 7499509. DOI: 10.1093/cid/ciaa1280. View

4.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

5.
Vinhaes C, Oliveira-de-Souza D, Silveira-Mattos P, Nogueira B, Shi R, Wei W . Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study. Cytokine. 2019; 123:154759. PMC: 6739167. DOI: 10.1016/j.cyto.2019.154759. View